Head-to-Head

Dyne Therapeutics, Inc. Common Stock vs. Eli Lilly & Co.

DYN

Dyne Therapeutics, Inc. Common Stock

$20.31 -16.35%

VS LLY

Eli Lilly & Co.

$1125.85 +0.17%

Eli Lilly & Co. (LLY) comes out ahead, leading on 5 of 6 compared factors.

Size & Scale

DYNLLY
Market Cap $3.79 billion $1.00 trillion
Revenue (TTM) — $79.67 billion
Net Income (TTM) $-519,406,000 $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

DYNLLY
P/E Ratio — 37.79
Price / Book 5.40 29.57
Price / Sales — 12.58

DYN leads on 1 of 1 valuation factors.

Profitability

DYNLLY
Net Margin — 33.53%
Return on Equity -73.97% 78.84%

LLY leads on 1 of 1 profitability factors.

Dividend

DYNLLY
Dividend Yield — 0.61%
Payout Ratio — 23.23

DYN and LLY split the dividend factors evenly.

Risk & Sentiment

DYNLLY
Short Interest 11.72% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: DYN overview, DYN financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.